Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model (Q45868408)

17 December 2017

title

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model (English)

1 reference

17 December 2017

0 references

1 reference

Horiguchi Y

1

1 reference

17 December 2017

Larchian WA

2

1 reference

17 December 2017

Kaplinsky R

3

1 reference

17 December 2017

Fair WR

4

1 reference

17 December 2017

Heston WD

5

1 reference

17 December 2017

publication date

1 May 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

844-851

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301157

exact match

0 references

cites work

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Biology and management of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Treatment of experimental mouse bladder tumour by LPS-induced epithelial cell shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Improved cationic lipid formulations for in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

In vivo gene transfer methods in the bladder without viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

Improvements in cationic liposomes for in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301157

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301157

1 reference

17 December 2017

Dimensions Publication ID

1039841840

0 references

Fatcat ID

release_lzhrrrexzrc4fiaetgkwgfiwfy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lzhrrrexzrc4fiaetgkwgfiwfy

24 November 2022

mapped directly with Wikidata item

PubMed ID

10845722

1 reference

17 December 2017